Skip to main content

Table 1 Baseline characteristics for each type of anticoagulation

From: Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?

  VKA (n = 1021) DOAC (n = 426) Total (n = 1447) p
Demographic characteristic
 Sex, male, [n (%)] 508 (49.8) 217 (50.9) 725 (50.1) 0.681
 Age (years), med (IQR) 80 (74–85) 80 (74–85) 80 (74–85) 0.240
Comorbidities
 HAS-BLED Score, [med (iqr)] 3 (2–3) 3 (2–3) 3 (2–3) 0.083
 Charlson Comorbidity Index, [med (iqr)] 6 (4–8) 6 (5–8) 6 (4–8) 0.015
 No. of drugs, [med (iqr)] 7 (4–10) 8 (5–10) 7 (5–10) 0.008
 No. of diagnoses, [med (iqr)] 5 (4–6) 5 (4–6) 5 (4–6) 0.004
 Hypertension, [n (%)] 744 (72.9) 325 (76.3) 1069 (73.9) 0.177
 Diabetes, [n (%)] 229 (22.4) 99 (23.2) 328 (22.7) 0.737
 CHF, [n (%)] 225 (22.0) 103 (24.2) 328 (22.7) 0.375
 Coronary artery disease, [n (%)] 97 (9.5) 43 (10.1) 140 (9.7) 0.728
 Cerebrovascular disease,[n (%)] 228 (22.3) 131 (30.8) 359 (24.8) 0.001
 Hemiplegia, [n (%)] 115 (11.3) 50 (11.7) 165 (11.4) 0.796
 Renal insufficiency, [n (%)] 401 (39.3) 145 (34.0) 546 (37.7) 0.061
 PAVD, [n (%)] 117 (11.5) 27 (6.3) 144 (10.0) 0.003
 Liver disease, [n (%)] 17 (1.7) 13 (3.1) 30 (2.1) 0.092
 COPD, [n (%)] 98 (9.6) 53 (12.4) 151 (10.4) 0.107
 Malignancy, [n (%)] 104 (10.2) 59 (13.8) 163 (11.3) 0.045
 Dementia, [n (%)] 106 (10.4) 73 (17.1) 179 (12.4) < 0.001
 Alcoholism, [n (%)] 8 (0.8) 14 (3.3) 22 (1.5) < 0.001
 Connective tissue disease, [n (%)] 36 (3.5) 14 (3.3) 50 (3.5) 0.820
 Peptic ulcer disease, [n (%)] 174 (17.0) 94 (22.1) 268 (18.5) 0.025
 AIDS, [n (%)] 0 (0.0) 0 (0.0) 0 (0.0)
 History of bleeding, [n (%)] 177 (17.3) 78 (18.3) 255 (17.6) 0.658
  1. Abbreviations: CHF Congestive heart failure, COPD Chronic obstructive pulmonary disease, CVI Cerebrovascular insult, DOAC Direct oral anticoagulant, iqr Interquartile range, med Median, TIA Transient ischemic attack, PAVD Peripheral artery disease, VKA Vitamin K antagonist